American pharmaceutical company Eli Lilly has introduced higher doses of its weight-loss drug Zepbound in vials, selling them at a discount of $150 compared to injector pens. This move aims to boost demand for the drug and compete with Novo Nordisk's Wegovy.
Eli Lilly Offers Zepbound in Cheaper Vials to Boost Demand
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →